Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study

Autor: Sharma, Abhipree, Wood, Stephen, Bell, J. Simon, De Blasio, Miles J., Ilomäki, Jenni, Ritchie, Rebecca H.
Zdroj: In The Lancet Regional Health - Western Pacific April 2023 33
Databáze: ScienceDirect